Rheumatology NewsDEA Training Mandate: 8 Hours of My Life I’d Like BackJune 14, 2024PainBusiness of Medicine
Rheumatology NewsWhat’s in a Name: Defining Difficult-to-Treat axSpA and PsAJune 14, 2024SpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Rheumatology NewsAutoantibodies Nonspecific to Systemic Sclerosis May Play Role in ILD PredictionJune 14, 2024Lupus & Connective Tissue Diseases
Rheumatology NewsLow Infection Risk, Apart from Herpes Zoster, Seen in Real-World JAK Inhibitor Data for RAJune 14, 2024Rheumatoid Arthritis
Rheumatology NewsUpadacitinib Proves Successful in First JAK Inhibitor Trial for Giant Cell ArteritisJune 14, 2024Lupus & Connective Tissue DiseasesVasculitis
Predictors of Radiographic Progression in Early PsA in a Real-World StudyJune 14, 2024Psoriatic Arthritis
Ixekizumab Effective in PsA Irrespective of Extent of Initial Skin InvolvementJune 14, 2024Psoriatic Arthritis
Bimekizumab Eases Disease Impact in bDMARD-naive, TNFi-IR Patients with PsAJune 14, 2024Psoriatic Arthritis
Real-World Prevalence and Clinical Characteristics of Difficult-To-Treat PsA June 14, 2024Psoriatic Arthritis
Low Stress Resilience in Adolescence Raises Risk for Psoriatic ArthritisJune 14, 2024Psoriatic Arthritis
